NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
<p>There are no clinically useful inhibitors of metallo-Β-lactamases (MBLs), which are a growing problem because they hydrolyse almost all Β-lactam antibacterials. Inhibition by most reported MBL inhibitors involves zinc ion chelation. A structure-based virtual screening approach combined with...
Main Authors: | Li, G, Abboud, M, Brem, J, Someya, H, Lohans, C, Yang, S, Spencer, J, Wareham, D, McDonough, M, Schofield, C |
---|---|
Format: | Journal article |
Published: |
Royal Society of Chemistry
2017
|
Similar Items
-
New Delhi metallo-beta-lactamase 1 catalyzes avibactam and aztreonam hydrolysis
by: Lohans, C, et al.
Published: (2017) -
New Delhi metallo-β-lactamase-1 catalyses avibactam and aztreonam hydrolysis.
by: Lohans, C, et al.
Published: (2017) -
Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition
by: Li, G, et al.
Published: (2017) -
Faropenem reacts with serine and metallo-β-lactamases to give multiple products
by: Lucic, A, et al.
Published: (2021) -
Use of ferrous iron by metallo-β-lactamases.
by: Cahill, S, et al.
Published: (2016)